BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Scholar Rock to Report Third Quarter 2025 Financial Results on November 14, 2025

  October 24, 2025

   · 

  2 min read
• Press Releases

  Sail Biomedicines Appoints Martin Mackay, Ph.D., to Its Board of Directors

  October 24, 2025

   · 

  2 min read
• Press Releases

  Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma

  October 24, 2025

   · 

  6 min read
• Press Releases

  IMUNON to Present New Translational Data from Phase 2 OVATION 2 Study of IMNN-001 at SITC 40th Annual Meeting

  October 24, 2025

   · 

  9 min read
• Press Releases

  Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV)

  October 24, 2025

   · 

  6 min read
• Press Releases

  Rentschler Biopharma Inc. named Manufacturer of the Year for Central Massachusetts

  October 24, 2025

   · 

  4 min read
• Press Releases

  Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025

  October 24, 2025

   · 

  1 min read
• Press Releases

  CAGE Bio Announces Start of Phase 2 Clinical Trial of Novel Topical DNA Aptamer Therapy CGB-600 for Vitiligo Treatment

  October 24, 2025

   · 

  2 min read
• Press Releases

  Verastem Oncology to Report Third Quarter 2025 Financial Results on November 4, 2025

  October 24, 2025

   · 

  1 min read
• Press Releases

  New York Regional Diabetes Research Center Receives $10M Award from NIH

  October 24, 2025

   · 

  7 min read